30 October 2014 : Short communication
Laparoendoscopic Single-Site Donor Nephrectomy: A Single-Center Initial Experience
Ercument GurlulerA, Ibrahim BerberB, Ulkem CakirBF, Alihan GurkanGDOI: 10.12659/AOT.892468
Ann Transplant 2014; 19:551-555
Abstract
Background
This study presents our initial experience with laparoendoscopic single-site donor nephrectomy. Ten patients (8 females, 2 males; mean age 45.3±13.2 years) underwent LESS-DN.
Material and Methods
Transumbilical laparoscopic donor nephrectomy was performed using an SILS™ port. Standard laparoscopic instruments and a 30-degree angled camera were used during the surgery. We evaluated the following parameters: warm and cold ischemia time, duration of the operation, amount of blood loss during the operation, duration of hospitalization, creatinine level, and visual analogue scale score for pain at discharge.
Results
The means for duration of operation, warm ischemia time, and duration of hospitalization were 140 min, 194 s, and 1.4 days, respectively. Intraoperative and/or postoperative complications were not observed. Low pain score and cosmetic advantage were remarkable. All recipients had functional grafts. The results of our initial experience with LESS-DN appeared to be positive.
Conclusions
Further studies on the LESS-DN technique with larger series conducted in different centers are needed.
Keywords: Living Donors, Nephrectomy, Surgical Procedures, Minimally Invasive
In Press
Original article
Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant RejectionAnn Transplant In Press; DOI: 10.12659/AOT.944762
Original article
Risk Factors for Graft Failure After Penetrating Keratoplasty in Eastern China from 2018 to 2021Ann Transplant In Press; DOI: 10.12659/AOT.945388
Original article
Predictive Model for Post-Transplant Renal Fibrosis Using Ultrasound Shear Wave ElastographyAnn Transplant In Press; DOI: 10.12659/AOT.945699
Original article
The Long-Acting Glucagon-Like Peptide-2 Analog Apraglutide Enhances Intestinal Protection and Survival Afte...Ann Transplant In Press; DOI: 10.12659/AOT.945249
Most Viewed Current Articles
05 Apr 2022 : Original article 12,974
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 10,077
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,421
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,180
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860